1,463 results on '"Conaghan P"'
Search Results
52. Sexual History Evidence and the Rape Trial
53. Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
54. Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
55. Improved Treatment Effect of Triamcinolone Acetonide Extended-Release in Patients with Concordant Baseline Pain Scores on the Average Daily Pain and Western Ontario and McMaster Universities Osteoarthritis Index Pain Scales
56. Real-world effectiveness and rheumatologist satisfaction with secukinumab in the treatment of patients with axial spondyloarthritis
57. Benefit–Risk Analysis of Upadacitinib Compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis
58. Free charge photogeneration in a single component high photovoltaic efficiency organic semiconductor
59. Prediction of flare following remission and treatment withdrawal in early rheumatoid arthritis: post hoc analysis of a phase IIIb trial with abatacept
60. Impact of tanezumab on health status, non-work activities and work productivity in adults with moderate-to-severe osteoarthritis
61. Physician and patient perceptions of surgical procedures for osteoarthritis of the knee in the United States, Europe, and Japan: results of a real-world study
62. Irish Grassland Research — main achievements and advancements in the past 60 yrs and where to progress to next
63. The efficacy and safety of a fixed-dose combination of apocynin and paeonol, APPA, in symptomatic knee OA: A double-blind, randomized, placebo-controlled, clinical trial.
64. Single and Composite Endpoints of Within-Patient Improvement in Symptoms: Pooled Tanezumab Data in Patients with Osteoarthritis
65. Harmonising measures of knee and hip osteoarthritis in population-based cohort studies: an international study
66. Atlas for the OMERACT thumb base osteoarthritis MRI scoring system (TOMS)
67. Prospects for Therapies in Osteoarthritis
68. Determination of Relative Weightings for Sacroiliac Joint Pathologies in the OMERACT Juvenile Arthritis Magnetic Resonance Imaging Sacroiliac Joint Score
69. Lehre in der Reanimation: Leitlinien des European Resuscitation Council 2021
70. Individual Participant Symptom Responses to Intra-Articular Lorecivivint in Knee Osteoarthritis: Post Hoc Analysis of a Phase 2B Trial
71. Upadacitinib in Rheumatoid Arthritis: A Benefit–Risk Assessment Across a Phase III Program
72. Ngaire Naffine: Criminal Law and the Man Problem: Hart Publishing, Oxford, 2019, ISBN: 9781509918010
73. Novel Fault Diagnosis of a Conveyor Belt Mis-Tracking via Motor Current Signature Analysis
74. Appraisal of quality and analysis of the similarities and differences between osteoarthritis Clinical Practice Guideline recommendations: A systematic review.
75. An Update on Imaging in Rheumatoid Arthritis
76. Outcomes following small bowel obstruction due to malignancy in the national audit of small bowel obstruction
77. Novel Diagnosis Technologies for a Lack of Oil Lubrication in Gearmotor Systems, Based on Motor Current Signature Analysis
78. Investigating the patient acceptable symptom state cut-offs: longitudinal data from a community cohort using the shoulder pain and disability index
79. Alternative and complementary therapies in osteoarthritis and cartilage repair
80. Rescue Analgesic Medication Use by Patients Treated with Triamcinolone Acetonide Extended-Release for Knee Osteoarthritis Pain: Pooled Analysis of Three Phase 2/3 Randomized Clinical Trials
81. Some reflections on law and gender in modern Ireland
82. Inflammatory Bowel Disease: Ulcerative Colitis
83. Ausbildung: COVID-19-Leitlinien des European Resuscitation Council
84. Determining MRI Inflammation Targets When Considering a Rheumatoid Arthritis Treat-to-Target Strategy: Results of a Randomized, Placebo-Controlled Trial
85. Practical guidance for engaging patients in health research, treatment guidelines and regulatory processes: results of an expert group meeting organized by the World Health Organization (WHO) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
86. Efficacy of Triamcinolone Acetonide Extended-Release in Participants with Unilateral Knee Osteoarthritis: A Post Hoc Analysis
87. Safety of Opioids in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis
88. Importance of Safety in the Management of Osteoarthritis and the Need for Updated Meta-Analyses and Recommendations for Reporting of Harms
89. Safety of Paracetamol in Osteoarthritis: What Does the Literature Say?
90. Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
91. POS0225 HOW WELL DOES ULTRASOUND-ASSESSED SYNOVITIS IN REDUCED JOINT SETS PREDICT THE RESPONSE TO SECUKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO CONVENTIONAL DMARDS? - EXPLORATORY RESULTS FROM A PHASE 3B STUDY
92. POS1260 SYSTEMATIC LITERATURE REVIEW FOR THE 2023 UPDATE OF EULAR RECOMMENDATIONS FOR THE TREATMENT OF SYSTEMIC SCLEROSIS
93. POS1348 EFFECTS OF SPRIFERMIN ON A NOVEL OUTCOME OF OSTEOARTHRITIS SYMPTOM PROGRESSION: POST-HOC ANALYSIS OF THE FORWARD RANDOMIZED TRIAL
94. POS0077-HPR ENHANCING CURRENT GUIDANCE FOR PSORIATIC ARTHRITIS AND ITS COMORBIDITIES: RECOMMENDATIONS FROM AN EXPERT CONSENSUS PANEL OF HEALTHCARE PROFESSIONALS IN THE UK
95. OP0076 UPDATE OF THE EULAR RECOMMENDATIONS FOR THE NON-PHARMACOLOGICAL CORE MANAGEMENT OF HIP AND KNEE OSTEOARTHRITIS
96. AB1185 POLYACRYLAMIDE HYDROGEL FOR THE TREATMENT OF KNEE OSTEOARTHRITIS: 3 YEAR FOLLOW UP RESULTS OF A PROSPECTIVE CLINICAL STUDY
97. POS0106 INTRA-ARTICULAR MM-II, A NOVEL SUSPENSION OF LARGE EMPTY MULTILAMELLAR LIPOSOMES, IN PAINFUL KNEE OSTEOARTHRITIS: A 26 WEEK PHASE 2B RANDOMIZED TRIAL
98. OP0234 2023 UPDATE OF EULAR RECOMMENDATIONS FOR THE TREATMENT OF SYSTEMIC SCLEROSIS
99. OP0073 COLCHICINE TWICE DAILY FOR HAND OSTEOARTHRITIS: RESULTS FROM THE DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED COLOR TRIAL
100. AB1194 A PROOF OF PRINCIPLE DIETARY INTERVENTION TRIAL TO EXAMINE THE PROTECTIVE EFFECT OF BROCCOLI BIOACTIVES, (SPECIFICALLY SULFORAPHANE), ON OSTEOARTHRITIS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.